US EditionPublished • loading... • Updated
Sonoma Biotherapeutics Appoints Rajesh Krishnan, Ph.D., as Chief Technical Officer
Summary by Citybiz
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Sonoma Biotherapeutics Appoints Rajesh Krishnan, Ph.D., as Chief Technical Officer
SOUTH SAN FRANCISCO, Calif. & SEATTLE–(BUSINESS WIRE)–Sonoma Biotherapeutics, a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the appointment of Rajesh Krishnan, Ph.D., to the company’s executive management team as Chief Technical Officer (CTO). Dr. Krishnan joins Sonoma Biotherapeutics with over 25 years of industry experience in process de…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
